Skip to main content
. 2014 Jan;15(1):75–83. doi: 10.1631/jzus.B1300058

Table 2.

Mutagenicity of extract from PM samples collected at six ceramic factories (A–F)

Treatment Revertant colony of TA 100 per plate (n=6)
A B C D E F
 DMSO (negative control) 14±3 32±4 32±2 33±3 33±4 23±3
 AF-2 (positive control) 232±13 392±10 392±11 263±9 263±10 212±12
 PM extract 10 μg 18±6 43±8 33±7 32±4 29±6 21±5
 PM extract 100 μg 23±4 42±10 35±6 39±7 31±3 14±4
 PM extract 350 μg 14±5 33±9 30±5 18±8 22±5 39±3

AF-2: 2-(2-furyl)-3-(5-nitro-2-furyl)acrylamide